nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—ASIC2—endometrium—ovarian cancer	0.0114	0.0314	CbGeAlD
Amiloride—AOC1—embryo—ovarian cancer	0.00981	0.0271	CbGeAlD
Amiloride—SLC9A1—embryo—ovarian cancer	0.0094	0.026	CbGeAlD
Amiloride—PLAU—myometrium—ovarian cancer	0.00927	0.0256	CbGeAlD
Amiloride—SCNN1D—epithelium—ovarian cancer	0.00816	0.0226	CbGeAlD
Amiloride—SCNN1G—uterine cervix—ovarian cancer	0.00809	0.0224	CbGeAlD
Amiloride—SLC9A1—epithelium—ovarian cancer	0.00767	0.0212	CbGeAlD
Amiloride—SLC9A1—uterine cervix—ovarian cancer	0.00761	0.021	CbGeAlD
Amiloride—AOC1—decidua—ovarian cancer	0.00757	0.0209	CbGeAlD
Amiloride—SCNN1G—endometrium—ovarian cancer	0.00732	0.0202	CbGeAlD
Amiloride—PLAU—epithelium—ovarian cancer	0.00727	0.0201	CbGeAlD
Amiloride—PLAU—uterine cervix—ovarian cancer	0.00721	0.0199	CbGeAlD
Amiloride—AOC1—endometrium—ovarian cancer	0.00718	0.0199	CbGeAlD
Amiloride—SCNN1B—epithelium—ovarian cancer	0.00689	0.0191	CbGeAlD
Amiloride—PLAU—decidua—ovarian cancer	0.00687	0.019	CbGeAlD
Amiloride—SCNN1B—uterine cervix—ovarian cancer	0.00684	0.0189	CbGeAlD
Amiloride—SCNN1D—gonad—ovarian cancer	0.00679	0.0188	CbGeAlD
Amiloride—PLAU—endometrium—ovarian cancer	0.00652	0.018	CbGeAlD
Amiloride—SCNN1B—decidua—ovarian cancer	0.00651	0.018	CbGeAlD
Amiloride—SCNN1A—epithelium—ovarian cancer	0.00637	0.0176	CbGeAlD
Amiloride—SCNN1A—uterine cervix—ovarian cancer	0.00632	0.0175	CbGeAlD
Amiloride—SCNN1B—endometrium—ovarian cancer	0.00618	0.0171	CbGeAlD
Amiloride—SCNN1D—female reproductive system—ovarian cancer	0.00606	0.0168	CbGeAlD
Amiloride—SCNN1G—female reproductive system—ovarian cancer	0.00606	0.0168	CbGeAlD
Amiloride—SCNN1A—decidua—ovarian cancer	0.00602	0.0166	CbGeAlD
Amiloride—PLAU—uterus—ovarian cancer	0.00601	0.0166	CbGeAlD
Amiloride—AOC1—female reproductive system—ovarian cancer	0.00595	0.0164	CbGeAlD
Amiloride—ASIC1—female reproductive system—ovarian cancer	0.00595	0.0164	CbGeAlD
Amiloride—SCNN1B—gonad—ovarian cancer	0.00573	0.0159	CbGeAlD
Amiloride—SLC9A1—female reproductive system—ovarian cancer	0.0057	0.0158	CbGeAlD
Amiloride—AOC1—bone marrow—ovarian cancer	0.00562	0.0155	CbGeAlD
Amiloride—SCNN1G—vagina—ovarian cancer	0.00548	0.0152	CbGeAlD
Amiloride—ASIC1—female gonad—ovarian cancer	0.00541	0.015	CbGeAlD
Amiloride—PLAU—female reproductive system—ovarian cancer	0.0054	0.0149	CbGeAlD
Amiloride—AOC1—vagina—ovarian cancer	0.00538	0.0149	CbGeAlD
Amiloride—SLC9A1—bone marrow—ovarian cancer	0.00538	0.0149	CbGeAlD
Amiloride—SCNN1A—uterus—ovarian cancer	0.00526	0.0145	CbGeAlD
Amiloride—SLC9A1—female gonad—ovarian cancer	0.00519	0.0143	CbGeAlD
Amiloride—SCNN1B—female reproductive system—ovarian cancer	0.00512	0.0142	CbGeAlD
Amiloride—PLAU—bone marrow—ovarian cancer	0.0051	0.0141	CbGeAlD
Amiloride—PLAU—female gonad—ovarian cancer	0.00492	0.0136	CbGeAlD
Amiloride—SCNN1D—testis—ovarian cancer	0.00489	0.0135	CbGeAlD
Amiloride—PLAU—vagina—ovarian cancer	0.00489	0.0135	CbGeAlD
Amiloride—ASIC1—testis—ovarian cancer	0.0048	0.0133	CbGeAlD
Amiloride—AOC1—testis—ovarian cancer	0.0048	0.0133	CbGeAlD
Amiloride—SCNN1A—female reproductive system—ovarian cancer	0.00473	0.0131	CbGeAlD
Amiloride—SCNN1B—vagina—ovarian cancer	0.00463	0.0128	CbGeAlD
Amiloride—SLC9A1—testis—ovarian cancer	0.0046	0.0127	CbGeAlD
Amiloride—PLAU—testis—ovarian cancer	0.00436	0.0121	CbGeAlD
Amiloride—SCNN1A—female gonad—ovarian cancer	0.00431	0.0119	CbGeAlD
Amiloride—SCNN1B—testis—ovarian cancer	0.00413	0.0114	CbGeAlD
Amiloride—SCNN1A—testis—ovarian cancer	0.00382	0.0106	CbGeAlD
Amiloride—SCNN1D—lymph node—ovarian cancer	0.00355	0.0098	CbGeAlD
Amiloride—ASIC1—lymph node—ovarian cancer	0.00348	0.00962	CbGeAlD
Amiloride—AOC1—lymph node—ovarian cancer	0.00348	0.00962	CbGeAlD
Amiloride—SLC9A1—lymph node—ovarian cancer	0.00333	0.00921	CbGeAlD
Amiloride—SLC22A4—myometrium—ovarian cancer	0.00325	0.00899	CbGeAlD
Amiloride—PLAU—lymph node—ovarian cancer	0.00316	0.00874	CbGeAlD
Amiloride—SCNN1B—lymph node—ovarian cancer	0.003	0.00828	CbGeAlD
Amiloride—SCNN1A—lymph node—ovarian cancer	0.00277	0.00765	CbGeAlD
Amiloride—SLC22A4—decidua—ovarian cancer	0.00241	0.00666	CbGeAlD
Amiloride—SLC22A4—endometrium—ovarian cancer	0.00229	0.00632	CbGeAlD
Amiloride—SLC22A4—female reproductive system—ovarian cancer	0.0019	0.00524	CbGeAlD
Amiloride—SLC22A4—bone marrow—ovarian cancer	0.00179	0.00495	CbGeAlD
Amiloride—SLC22A4—vagina—ovarian cancer	0.00171	0.00474	CbGeAlD
Amiloride—SLC22A1—vagina—ovarian cancer	0.00163	0.00451	CbGeAlD
Amiloride—SLC22A4—lymph node—ovarian cancer	0.00111	0.00306	CbGeAlD
Amiloride—SLC9A1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000974	0.00341	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.00097	0.00339	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL2—ovarian cancer	0.000966	0.00338	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—CTNNB1—ovarian cancer	0.000966	0.00338	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CG—ovarian cancer	0.000964	0.00337	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—APC—ovarian cancer	0.000964	0.00337	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—MAPK3—ovarian cancer	0.000956	0.00335	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—CDKN1B—ovarian cancer	0.000955	0.00334	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000952	0.00333	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—ovarian cancer	0.000946	0.00331	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CCND1—ovarian cancer	0.000942	0.0033	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—SLC2A1—ovarian cancer	0.000939	0.00329	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—MAPK3—ovarian cancer	0.000937	0.00328	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000936	0.00328	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000934	0.00327	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.000933	0.00327	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—MMP9—ovarian cancer	0.000915	0.0032	CbGpPWpGaD
Amiloride—Neck pain—Doxorubicin—ovarian cancer	0.000913	0.00259	CcSEcCtD
Amiloride—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000913	0.00259	CcSEcCtD
Amiloride—Fatigue—Topotecan—ovarian cancer	0.000911	0.00258	CcSEcCtD
Amiloride—Dyspepsia—Melphalan—ovarian cancer	0.000911	0.00258	CcSEcCtD
Amiloride—PLAU—FGF signaling pathway—MAPK1—ovarian cancer	0.00091	0.00319	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—PTEN—ovarian cancer	0.000909	0.00318	CbGpPWpGaD
Amiloride—Pain—Topotecan—ovarian cancer	0.000904	0.00256	CcSEcCtD
Amiloride—Constipation—Topotecan—ovarian cancer	0.000904	0.00256	CcSEcCtD
Amiloride—Hepatocellular injury—Doxorubicin—ovarian cancer	0.000902	0.00256	CcSEcCtD
Amiloride—Decreased appetite—Melphalan—ovarian cancer	0.0009	0.00255	CcSEcCtD
Amiloride—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000894	0.00253	CcSEcCtD
Amiloride—Fatigue—Melphalan—ovarian cancer	0.000892	0.00253	CcSEcCtD
Amiloride—SLC9A1—Endothelins—MAPK1—ovarian cancer	0.000892	0.00312	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—MAPK3—ovarian cancer	0.000891	0.00312	CbGpPWpGaD
Amiloride—Coma—Epirubicin—ovarian cancer	0.000891	0.00253	CcSEcCtD
Amiloride—Hyperkalaemia—Doxorubicin—ovarian cancer	0.000886	0.00251	CcSEcCtD
Amiloride—Pain—Melphalan—ovarian cancer	0.000885	0.00251	CcSEcCtD
Amiloride—Angina pectoris—Docetaxel—ovarian cancer	0.000883	0.0025	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—VEGFA—ovarian cancer	0.000882	0.00309	CbGpPWpGaD
Amiloride—Bradycardia—Paclitaxel—ovarian cancer	0.000872	0.00247	CcSEcCtD
Amiloride—Feeling abnormal—Topotecan—ovarian cancer	0.000871	0.00247	CcSEcCtD
Amiloride—Gastrointestinal pain—Topotecan—ovarian cancer	0.000864	0.00245	CcSEcCtD
Amiloride—Anorexia—Vinorelbine—ovarian cancer	0.000862	0.00244	CcSEcCtD
Amiloride—PLAU—Beta1 integrin cell surface interactions—VEGFA—ovarian cancer	0.000861	0.00301	CbGpPWpGaD
Amiloride—Haemoglobin—Paclitaxel—ovarian cancer	0.00086	0.00244	CcSEcCtD
Amiloride—Haemorrhage—Paclitaxel—ovarian cancer	0.000856	0.00243	CcSEcCtD
Amiloride—Asthenia—Chlorambucil—ovarian cancer	0.000852	0.00242	CcSEcCtD
Amiloride—Neutropenia—Docetaxel—ovarian cancer	0.000848	0.0024	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—MAPK1—ovarian cancer	0.000848	0.00297	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CD—ovarian cancer	0.000847	0.00297	CbGpPWpGaD
Amiloride—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000847	0.0024	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—PIK3CB—ovarian cancer	0.000844	0.00295	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—MTOR—ovarian cancer	0.000844	0.00295	CbGpPWpGaD
Amiloride—Pruritus—Chlorambucil—ovarian cancer	0.00084	0.00238	CcSEcCtD
Amiloride—Abdominal pain—Topotecan—ovarian cancer	0.000836	0.00237	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CG—ovarian cancer	0.000832	0.00291	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—APC—ovarian cancer	0.000832	0.00291	CbGpPWpGaD
Amiloride—Visual impairment—Paclitaxel—ovarian cancer	0.000825	0.00234	CcSEcCtD
Amiloride—Coma—Doxorubicin—ovarian cancer	0.000824	0.00234	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000824	0.00234	CcSEcCtD
Amiloride—Diarrhoea—Chlorambucil—ovarian cancer	0.000812	0.0023	CcSEcCtD
Amiloride—Paraesthesia—Vinorelbine—ovarian cancer	0.000812	0.0023	CcSEcCtD
Amiloride—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00081	0.0023	CcSEcCtD
Amiloride—Dyspnoea—Vinorelbine—ovarian cancer	0.000806	0.00229	CcSEcCtD
Amiloride—SLC9A1—Carbohydrate metabolism—PPP2R1A—ovarian cancer	0.000799	0.0028	CbGpPWpGaD
Amiloride—Tinnitus—Paclitaxel—ovarian cancer	0.000798	0.00226	CcSEcCtD
Amiloride—SLC9A1—Disease—CHMP4C—ovarian cancer	0.000795	0.00278	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—PIK3CA—ovarian cancer	0.00079	0.00276	CbGpPWpGaD
Amiloride—Jaundice—Docetaxel—ovarian cancer	0.000788	0.00223	CcSEcCtD
Amiloride—Decreased appetite—Vinorelbine—ovarian cancer	0.000786	0.00223	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway—MYC—ovarian cancer	0.000783	0.00274	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000781	0.00221	CcSEcCtD
Amiloride—Fatigue—Vinorelbine—ovarian cancer	0.00078	0.00221	CcSEcCtD
Amiloride—Constipation—Vinorelbine—ovarian cancer	0.000773	0.00219	CcSEcCtD
Amiloride—Pain—Vinorelbine—ovarian cancer	0.000773	0.00219	CcSEcCtD
Amiloride—SLC9A1—Metabolism—NME2—ovarian cancer	0.000762	0.00267	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—MTOR—ovarian cancer	0.000761	0.00266	CbGpPWpGaD
Amiloride—Asthenia—Topotecan—ovarian cancer	0.000758	0.00215	CcSEcCtD
Amiloride—Alopecia—Paclitaxel—ovarian cancer	0.000757	0.00215	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—MYC—ovarian cancer	0.000756	0.00265	CbGpPWpGaD
Amiloride—Vomiting—Chlorambucil—ovarian cancer	0.000755	0.00214	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000752	0.00263	CbGpPWpGaD
Amiloride—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000749	0.00212	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—ERBB2—ovarian cancer	0.000748	0.00262	CbGpPWpGaD
Amiloride—Pruritus—Topotecan—ovarian cancer	0.000748	0.00212	CcSEcCtD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000747	0.00262	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000747	0.00262	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000747	0.00262	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000747	0.00262	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000747	0.00262	CbGpPWpGaD
Amiloride—Feeling abnormal—Vinorelbine—ovarian cancer	0.000745	0.00211	CcSEcCtD
Amiloride—Asthenia—Melphalan—ovarian cancer	0.000743	0.00211	CcSEcCtD
Amiloride—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000739	0.0021	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000738	0.00259	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CB—ovarian cancer	0.000738	0.00259	CbGpPWpGaD
Amiloride—Flatulence—Paclitaxel—ovarian cancer	0.000734	0.00208	CcSEcCtD
Amiloride—Pruritus—Melphalan—ovarian cancer	0.000732	0.00208	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CD—ovarian cancer	0.000731	0.00256	CbGpPWpGaD
Amiloride—Tension—Paclitaxel—ovarian cancer	0.000731	0.00207	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CXCL8—ovarian cancer	0.000731	0.00256	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—MYC—ovarian cancer	0.000731	0.00256	CbGpPWpGaD
Amiloride—Haemoglobin—Docetaxel—ovarian cancer	0.000729	0.00207	CcSEcCtD
Amiloride—Haemorrhage—Docetaxel—ovarian cancer	0.000726	0.00206	CcSEcCtD
Amiloride—Nervousness—Paclitaxel—ovarian cancer	0.000724	0.00205	CcSEcCtD
Amiloride—Diarrhoea—Topotecan—ovarian cancer	0.000723	0.00205	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000722	0.00253	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000722	0.00253	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000722	0.00253	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000722	0.00253	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000722	0.00253	CbGpPWpGaD
Amiloride—Back pain—Paclitaxel—ovarian cancer	0.000721	0.00204	CcSEcCtD
Amiloride—SLC9A1—G Protein Signaling Pathways—NRAS—ovarian cancer	0.000717	0.00251	CbGpPWpGaD
Amiloride—Muscle spasms—Paclitaxel—ovarian cancer	0.000717	0.00203	CcSEcCtD
Amiloride—SLC9A1—Endothelins—HRAS—ovarian cancer	0.000716	0.00251	CbGpPWpGaD
Amiloride—Abdominal pain—Vinorelbine—ovarian cancer	0.000715	0.00203	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN1B—ovarian cancer	0.000714	0.0025	CbGpPWpGaD
Amiloride—Hyponatraemia—Epirubicin—ovarian cancer	0.00071	0.00201	CcSEcCtD
Amiloride—Diarrhoea—Melphalan—ovarian cancer	0.000708	0.00201	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000708	0.00201	CcSEcCtD
Amiloride—Pain in extremity—Epirubicin—ovarian cancer	0.000708	0.00201	CcSEcCtD
Amiloride—Nausea—Chlorambucil—ovarian cancer	0.000705	0.002	CcSEcCtD
Amiloride—Visual impairment—Docetaxel—ovarian cancer	0.000699	0.00198	CcSEcCtD
Amiloride—Dizziness—Topotecan—ovarian cancer	0.000699	0.00198	CcSEcCtD
Amiloride—Tremor—Paclitaxel—ovarian cancer	0.000698	0.00198	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CCND1—ovarian cancer	0.000697	0.00244	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN1B—ovarian cancer	0.000693	0.00243	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CTNNB1—ovarian cancer	0.00069	0.00242	CbGpPWpGaD
Amiloride—SLC9A1—Disease—BCL9—ovarian cancer	0.000689	0.00241	CbGpPWpGaD
Amiloride—Vomiting—Topotecan—ovarian cancer	0.000672	0.00191	CcSEcCtD
Amiloride—Vertigo—Paclitaxel—ovarian cancer	0.00067	0.0019	CcSEcCtD
Amiloride—Rash—Topotecan—ovarian cancer	0.000667	0.00189	CcSEcCtD
Amiloride—Dermatitis—Topotecan—ovarian cancer	0.000666	0.00189	CcSEcCtD
Amiloride—Headache—Topotecan—ovarian cancer	0.000662	0.00188	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CCND1—ovarian cancer	0.000661	0.00231	CbGpPWpGaD
Amiloride—Palpitations—Paclitaxel—ovarian cancer	0.000659	0.00187	CcSEcCtD
Amiloride—Vomiting—Melphalan—ovarian cancer	0.000658	0.00187	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—PTEN—ovarian cancer	0.000657	0.0023	CbGpPWpGaD
Amiloride—Hyponatraemia—Doxorubicin—ovarian cancer	0.000657	0.00186	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CTNNB1—ovarian cancer	0.000655	0.00229	CbGpPWpGaD
Amiloride—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000655	0.00186	CcSEcCtD
Amiloride—Pain in extremity—Doxorubicin—ovarian cancer	0.000655	0.00186	CcSEcCtD
Amiloride—Rash—Melphalan—ovarian cancer	0.000653	0.00185	CcSEcCtD
Amiloride—Dermatitis—Melphalan—ovarian cancer	0.000652	0.00185	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—STAT3—ovarian cancer	0.000652	0.00228	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—IL6—ovarian cancer	0.000651	0.00228	CbGpPWpGaD
Amiloride—Cough—Paclitaxel—ovarian cancer	0.00065	0.00184	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—NRAS—ovarian cancer	0.00065	0.00228	CbGpPWpGaD
Amiloride—Asthenia—Vinorelbine—ovarian cancer	0.000649	0.00184	CcSEcCtD
Amiloride—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000646	0.00183	CcSEcCtD
Amiloride—PLAU—FGF signaling pathway—AKT1—ovarian cancer	0.000645	0.00226	CbGpPWpGaD
Amiloride—Alopecia—Docetaxel—ovarian cancer	0.000641	0.00182	CcSEcCtD
Amiloride—Pruritus—Vinorelbine—ovarian cancer	0.00064	0.00181	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PTEN—ovarian cancer	0.000638	0.00223	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CB—ovarian cancer	0.000638	0.00223	CbGpPWpGaD
Amiloride—Arthralgia—Paclitaxel—ovarian cancer	0.000635	0.0018	CcSEcCtD
Amiloride—Chest pain—Paclitaxel—ovarian cancer	0.000635	0.0018	CcSEcCtD
Amiloride—SLC9A1—Endothelins—AKT1—ovarian cancer	0.000632	0.00221	CbGpPWpGaD
Amiloride—Nausea—Topotecan—ovarian cancer	0.000628	0.00178	CcSEcCtD
Amiloride—Muscular weakness—Epirubicin—ovarian cancer	0.000624	0.00177	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—MAPK3—ovarian cancer	0.000623	0.00218	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TP53—ovarian cancer	0.000621	0.00217	CbGpPWpGaD
Amiloride—Diarrhoea—Vinorelbine—ovarian cancer	0.000619	0.00175	CcSEcCtD
Amiloride—SLC9A1—G Protein Signaling Pathways—KRAS—ovarian cancer	0.000617	0.00216	CbGpPWpGaD
Amiloride—Abdominal distension—Epirubicin—ovarian cancer	0.000616	0.00175	CcSEcCtD
Amiloride—Nausea—Melphalan—ovarian cancer	0.000615	0.00174	CcSEcCtD
Amiloride—Confusional state—Paclitaxel—ovarian cancer	0.000613	0.00174	CcSEcCtD
Amiloride—Back pain—Docetaxel—ovarian cancer	0.000611	0.00173	CcSEcCtD
Amiloride—Muscle spasms—Docetaxel—ovarian cancer	0.000607	0.00172	CcSEcCtD
Amiloride—Shock—Paclitaxel—ovarian cancer	0.000598	0.0017	CcSEcCtD
Amiloride—Dizziness—Vinorelbine—ovarian cancer	0.000598	0.0017	CcSEcCtD
Amiloride—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000598	0.0017	CcSEcCtD
Amiloride—Angina pectoris—Epirubicin—ovarian cancer	0.000596	0.00169	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—MAPK1—ovarian cancer	0.000593	0.00207	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—EGFR—ovarian cancer	0.000592	0.00207	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SPARC—ovarian cancer	0.000583	0.00204	CbGpPWpGaD
Amiloride—Anorexia—Paclitaxel—ovarian cancer	0.00058	0.00164	CcSEcCtD
Amiloride—Muscular weakness—Doxorubicin—ovarian cancer	0.000577	0.00164	CcSEcCtD
Amiloride—Vomiting—Vinorelbine—ovarian cancer	0.000575	0.00163	CcSEcCtD
Amiloride—Dysuria—Epirubicin—ovarian cancer	0.000572	0.00162	CcSEcCtD
Amiloride—Neutropenia—Epirubicin—ovarian cancer	0.000572	0.00162	CcSEcCtD
Amiloride—Rash—Vinorelbine—ovarian cancer	0.00057	0.00162	CcSEcCtD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00057	0.002	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00057	0.002	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00057	0.002	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00057	0.002	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00057	0.002	CbGpPWpGaD
Amiloride—Dermatitis—Vinorelbine—ovarian cancer	0.00057	0.00162	CcSEcCtD
Amiloride—Abdominal distension—Doxorubicin—ovarian cancer	0.00057	0.00162	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—NRAS—ovarian cancer	0.000569	0.00199	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL6—ovarian cancer	0.000568	0.00199	CbGpPWpGaD
Amiloride—Headache—Vinorelbine—ovarian cancer	0.000567	0.00161	CcSEcCtD
Amiloride—SLC22A2—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000566	0.00198	CbGpPWpGaD
Amiloride—Pollakiuria—Epirubicin—ovarian cancer	0.000565	0.0016	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—AKT1—ovarian cancer	0.000563	0.00197	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—KRAS—ovarian cancer	0.00056	0.00196	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—MYC—ovarian cancer	0.000559	0.00196	CbGpPWpGaD
Amiloride—Palpitations—Docetaxel—ovarian cancer	0.000558	0.00158	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000554	0.00157	CcSEcCtD
Amiloride—Cough—Docetaxel—ovarian cancer	0.000551	0.00156	CcSEcCtD
Amiloride—Angina pectoris—Doxorubicin—ovarian cancer	0.000551	0.00156	CcSEcCtD
Amiloride—Insomnia—Paclitaxel—ovarian cancer	0.00055	0.00156	CcSEcCtD
Amiloride—Paraesthesia—Paclitaxel—ovarian cancer	0.000546	0.00155	CcSEcCtD
Amiloride—Dyspnoea—Paclitaxel—ovarian cancer	0.000542	0.00154	CcSEcCtD
Amiloride—Somnolence—Paclitaxel—ovarian cancer	0.000541	0.00153	CcSEcCtD
Amiloride—Arthralgia—Docetaxel—ovarian cancer	0.000538	0.00153	CcSEcCtD
Amiloride—Chest pain—Docetaxel—ovarian cancer	0.000538	0.00153	CcSEcCtD
Amiloride—Nausea—Vinorelbine—ovarian cancer	0.000537	0.00152	CcSEcCtD
Amiloride—Dyspepsia—Paclitaxel—ovarian cancer	0.000535	0.00152	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—MAPK1—ovarian cancer	0.000535	0.00187	CbGpPWpGaD
Amiloride—Jaundice—Epirubicin—ovarian cancer	0.000531	0.00151	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MYC—ovarian cancer	0.00053	0.00186	CbGpPWpGaD
Amiloride—Dysuria—Doxorubicin—ovarian cancer	0.000529	0.0015	CcSEcCtD
Amiloride—Neutropenia—Doxorubicin—ovarian cancer	0.000529	0.0015	CcSEcCtD
Amiloride—Decreased appetite—Paclitaxel—ovarian cancer	0.000529	0.0015	CcSEcCtD
Amiloride—SLC22A1—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000528	0.00185	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000525	0.00149	CcSEcCtD
Amiloride—Fatigue—Paclitaxel—ovarian cancer	0.000524	0.00149	CcSEcCtD
Amiloride—SLC9A1—G Protein Signaling Pathways—HRAS—ovarian cancer	0.000524	0.00184	CbGpPWpGaD
Amiloride—Pollakiuria—Doxorubicin—ovarian cancer	0.000523	0.00148	CcSEcCtD
Amiloride—Constipation—Paclitaxel—ovarian cancer	0.00052	0.00148	CcSEcCtD
Amiloride—Pain—Paclitaxel—ovarian cancer	0.00052	0.00148	CcSEcCtD
Amiloride—Confusional state—Docetaxel—ovarian cancer	0.00052	0.00147	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MAPK1—ovarian cancer	0.000519	0.00182	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—PIK3CA—ovarian cancer	0.000514	0.0018	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PPP1CC—ovarian cancer	0.000512	0.00179	CbGpPWpGaD
Amiloride—Shock—Docetaxel—ovarian cancer	0.000507	0.00144	CcSEcCtD
Amiloride—Feeling abnormal—Paclitaxel—ovarian cancer	0.000501	0.00142	CcSEcCtD
Amiloride—Bradycardia—Epirubicin—ovarian cancer	0.000498	0.00141	CcSEcCtD
Amiloride—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000497	0.00141	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000493	0.00173	CbGpPWpGaD
Amiloride—Haemoglobin—Epirubicin—ovarian cancer	0.000492	0.0014	CcSEcCtD
Amiloride—Jaundice—Doxorubicin—ovarian cancer	0.000492	0.00139	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—NRAS—ovarian cancer	0.000491	0.00172	CbGpPWpGaD
Amiloride—Anorexia—Docetaxel—ovarian cancer	0.000491	0.00139	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CYTB—ovarian cancer	0.000491	0.00172	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—KRAS—ovarian cancer	0.00049	0.00172	CbGpPWpGaD
Amiloride—Haemorrhage—Epirubicin—ovarian cancer	0.000489	0.00139	CcSEcCtD
Amiloride—Abdominal pain—Paclitaxel—ovarian cancer	0.000481	0.00136	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000476	0.00167	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—HRAS—ovarian cancer	0.000476	0.00167	CbGpPWpGaD
Amiloride—Visual impairment—Epirubicin—ovarian cancer	0.000472	0.00134	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MAPK3—ovarian cancer	0.000471	0.00165	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00047	0.00133	CcSEcCtD
Amiloride—Insomnia—Docetaxel—ovarian cancer	0.000466	0.00132	CcSEcCtD
Amiloride—Paraesthesia—Docetaxel—ovarian cancer	0.000463	0.00131	CcSEcCtD
Amiloride—Bradycardia—Doxorubicin—ovarian cancer	0.000461	0.00131	CcSEcCtD
Amiloride—Dyspnoea—Docetaxel—ovarian cancer	0.00046	0.0013	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—ovarian cancer	0.000459	0.00161	CbGpPWpGaD
Amiloride—Somnolence—Docetaxel—ovarian cancer	0.000458	0.0013	CcSEcCtD
Amiloride—Tinnitus—Epirubicin—ovarian cancer	0.000456	0.00129	CcSEcCtD
Amiloride—Haemoglobin—Doxorubicin—ovarian cancer	0.000455	0.00129	CcSEcCtD
Amiloride—Dyspepsia—Docetaxel—ovarian cancer	0.000454	0.00129	CcSEcCtD
Amiloride—Haemorrhage—Doxorubicin—ovarian cancer	0.000453	0.00128	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CA—ovarian cancer	0.00045	0.00158	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—ovarian cancer	0.000449	0.00157	CbGpPWpGaD
Amiloride—Decreased appetite—Docetaxel—ovarian cancer	0.000448	0.00127	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MAPK1—ovarian cancer	0.000448	0.00157	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—EGFR—ovarian cancer	0.000448	0.00157	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000446	0.00156	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000445	0.00126	CcSEcCtD
Amiloride—Fatigue—Docetaxel—ovarian cancer	0.000444	0.00126	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000444	0.00155	CbGpPWpGaD
Amiloride—Pain—Docetaxel—ovarian cancer	0.000441	0.00125	CcSEcCtD
Amiloride—Constipation—Docetaxel—ovarian cancer	0.000441	0.00125	CcSEcCtD
Amiloride—Visual impairment—Doxorubicin—ovarian cancer	0.000436	0.00124	CcSEcCtD
Amiloride—Asthenia—Paclitaxel—ovarian cancer	0.000436	0.00124	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—ovarian cancer	0.000435	0.00152	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—NSF—ovarian cancer	0.000434	0.00152	CbGpPWpGaD
Amiloride—Alopecia—Epirubicin—ovarian cancer	0.000433	0.00123	CcSEcCtD
Amiloride—Pruritus—Paclitaxel—ovarian cancer	0.00043	0.00122	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—HRAS—ovarian cancer	0.000429	0.0015	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPP1CC—ovarian cancer	0.000429	0.0015	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—BRIP1—ovarian cancer	0.000429	0.0015	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000429	0.0015	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000428	0.0015	CbGpPWpGaD
Amiloride—Feeling abnormal—Docetaxel—ovarian cancer	0.000425	0.0012	CcSEcCtD
Amiloride—PLAU—Hemostasis—SOD1—ovarian cancer	0.000424	0.00148	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—KRAS—ovarian cancer	0.000423	0.00148	CbGpPWpGaD
Amiloride—Tinnitus—Doxorubicin—ovarian cancer	0.000422	0.0012	CcSEcCtD
Amiloride—PLAU—Hemostasis—PPP2R1A—ovarian cancer	0.000422	0.00148	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000422	0.0012	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—AKT1—ovarian cancer	0.00042	0.00147	CbGpPWpGaD
Amiloride—Flatulence—Epirubicin—ovarian cancer	0.00042	0.00119	CcSEcCtD
Amiloride—Tension—Epirubicin—ovarian cancer	0.000418	0.00119	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—HRAS—ovarian cancer	0.000416	0.00146	CbGpPWpGaD
Amiloride—Diarrhoea—Paclitaxel—ovarian cancer	0.000416	0.00118	CcSEcCtD
Amiloride—Nervousness—Epirubicin—ovarian cancer	0.000414	0.00117	CcSEcCtD
Amiloride—Back pain—Epirubicin—ovarian cancer	0.000412	0.00117	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—ovarian cancer	0.000411	0.00144	CbGpPWpGaD
Amiloride—Muscle spasms—Epirubicin—ovarian cancer	0.00041	0.00116	CcSEcCtD
Amiloride—Abdominal pain—Docetaxel—ovarian cancer	0.000408	0.00116	CcSEcCtD
Amiloride—SLC22A1—Neuronal System—NSF—ovarian cancer	0.000404	0.00142	CbGpPWpGaD
Amiloride—Dizziness—Paclitaxel—ovarian cancer	0.000402	0.00114	CcSEcCtD
Amiloride—Alopecia—Doxorubicin—ovarian cancer	0.0004	0.00113	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CA—ovarian cancer	0.000389	0.00136	CbGpPWpGaD
Amiloride—Flatulence—Doxorubicin—ovarian cancer	0.000388	0.0011	CcSEcCtD
Amiloride—SLC9A1—Disease—HDAC6—ovarian cancer	0.000388	0.00136	CbGpPWpGaD
Amiloride—Tension—Doxorubicin—ovarian cancer	0.000387	0.0011	CcSEcCtD
Amiloride—Vomiting—Paclitaxel—ovarian cancer	0.000387	0.0011	CcSEcCtD
Amiloride—Rash—Paclitaxel—ovarian cancer	0.000384	0.00109	CcSEcCtD
Amiloride—Dermatitis—Paclitaxel—ovarian cancer	0.000383	0.00109	CcSEcCtD
Amiloride—Nervousness—Doxorubicin—ovarian cancer	0.000383	0.00109	CcSEcCtD
Amiloride—Vertigo—Epirubicin—ovarian cancer	0.000383	0.00109	CcSEcCtD
Amiloride—Back pain—Doxorubicin—ovarian cancer	0.000381	0.00108	CcSEcCtD
Amiloride—Headache—Paclitaxel—ovarian cancer	0.000381	0.00108	CcSEcCtD
Amiloride—Muscle spasms—Doxorubicin—ovarian cancer	0.000379	0.00107	CcSEcCtD
Amiloride—Palpitations—Epirubicin—ovarian cancer	0.000377	0.00107	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000376	0.00132	CbGpPWpGaD
Amiloride—Cough—Epirubicin—ovarian cancer	0.000372	0.00105	CcSEcCtD
Amiloride—Asthenia—Docetaxel—ovarian cancer	0.00037	0.00105	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—AKT1—ovarian cancer	0.000368	0.00129	CbGpPWpGaD
Amiloride—Pruritus—Docetaxel—ovarian cancer	0.000365	0.00103	CcSEcCtD
Amiloride—Arthralgia—Epirubicin—ovarian cancer	0.000363	0.00103	CcSEcCtD
Amiloride—Chest pain—Epirubicin—ovarian cancer	0.000363	0.00103	CcSEcCtD
Amiloride—Nausea—Paclitaxel—ovarian cancer	0.000361	0.00102	CcSEcCtD
Amiloride—Vertigo—Doxorubicin—ovarian cancer	0.000354	0.001	CcSEcCtD
Amiloride—Diarrhoea—Docetaxel—ovarian cancer	0.000353	0.001	CcSEcCtD
Amiloride—Confusional state—Epirubicin—ovarian cancer	0.000351	0.000994	CcSEcCtD
Amiloride—Palpitations—Doxorubicin—ovarian cancer	0.000348	0.000988	CcSEcCtD
Amiloride—Cough—Doxorubicin—ovarian cancer	0.000344	0.000976	CcSEcCtD
Amiloride—Shock—Epirubicin—ovarian cancer	0.000342	0.00097	CcSEcCtD
Amiloride—Dizziness—Docetaxel—ovarian cancer	0.000341	0.000967	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000338	0.00118	CbGpPWpGaD
Amiloride—SLC9A1—Disease—XIAP—ovarian cancer	0.000337	0.00118	CbGpPWpGaD
Amiloride—Arthralgia—Doxorubicin—ovarian cancer	0.000336	0.000952	CcSEcCtD
Amiloride—Chest pain—Doxorubicin—ovarian cancer	0.000336	0.000952	CcSEcCtD
Amiloride—Anorexia—Epirubicin—ovarian cancer	0.000331	0.00094	CcSEcCtD
Amiloride—SLC9A1—Disease—SMARCA4—ovarian cancer	0.000328	0.00115	CbGpPWpGaD
Amiloride—Vomiting—Docetaxel—ovarian cancer	0.000328	0.00093	CcSEcCtD
Amiloride—Rash—Docetaxel—ovarian cancer	0.000325	0.000922	CcSEcCtD
Amiloride—Dermatitis—Docetaxel—ovarian cancer	0.000325	0.000921	CcSEcCtD
Amiloride—Confusional state—Doxorubicin—ovarian cancer	0.000324	0.00092	CcSEcCtD
Amiloride—Headache—Docetaxel—ovarian cancer	0.000323	0.000916	CcSEcCtD
Amiloride—SLC9A1—Disease—EREG—ovarian cancer	0.00032	0.00112	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000317	0.000898	CcSEcCtD
Amiloride—Shock—Doxorubicin—ovarian cancer	0.000317	0.000898	CcSEcCtD
Amiloride—Insomnia—Epirubicin—ovarian cancer	0.000315	0.000892	CcSEcCtD
Amiloride—Paraesthesia—Epirubicin—ovarian cancer	0.000312	0.000886	CcSEcCtD
Amiloride—Dyspnoea—Epirubicin—ovarian cancer	0.00031	0.000879	CcSEcCtD
Amiloride—PLAU—Hemostasis—CAV1—ovarian cancer	0.00031	0.00108	CbGpPWpGaD
Amiloride—Somnolence—Epirubicin—ovarian cancer	0.000309	0.000877	CcSEcCtD
Amiloride—Anorexia—Doxorubicin—ovarian cancer	0.000307	0.00087	CcSEcCtD
Amiloride—Nausea—Docetaxel—ovarian cancer	0.000306	0.000868	CcSEcCtD
Amiloride—Dyspepsia—Epirubicin—ovarian cancer	0.000306	0.000868	CcSEcCtD
Amiloride—Decreased appetite—Epirubicin—ovarian cancer	0.000302	0.000857	CcSEcCtD
Amiloride—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.0003	0.000851	CcSEcCtD
Amiloride—Fatigue—Epirubicin—ovarian cancer	0.0003	0.00085	CcSEcCtD
Amiloride—Constipation—Epirubicin—ovarian cancer	0.000297	0.000843	CcSEcCtD
Amiloride—Pain—Epirubicin—ovarian cancer	0.000297	0.000843	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000293	0.000831	CcSEcCtD
Amiloride—Insomnia—Doxorubicin—ovarian cancer	0.000291	0.000825	CcSEcCtD
Amiloride—Paraesthesia—Doxorubicin—ovarian cancer	0.000289	0.000819	CcSEcCtD
Amiloride—SLC9A1—Metabolism—YAP1—ovarian cancer	0.000288	0.00101	CbGpPWpGaD
Amiloride—Dyspnoea—Doxorubicin—ovarian cancer	0.000287	0.000814	CcSEcCtD
Amiloride—Feeling abnormal—Epirubicin—ovarian cancer	0.000287	0.000813	CcSEcCtD
Amiloride—Somnolence—Doxorubicin—ovarian cancer	0.000286	0.000811	CcSEcCtD
Amiloride—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000284	0.000806	CcSEcCtD
Amiloride—Dyspepsia—Doxorubicin—ovarian cancer	0.000283	0.000803	CcSEcCtD
Amiloride—PLAU—Hemostasis—PIK3CG—ovarian cancer	0.000282	0.000988	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FASN—ovarian cancer	0.00028	0.000981	CbGpPWpGaD
Amiloride—Decreased appetite—Doxorubicin—ovarian cancer	0.00028	0.000793	CcSEcCtD
Amiloride—SLC9A1—Disease—PARP1—ovarian cancer	0.000279	0.000977	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000278	0.000788	CcSEcCtD
Amiloride—Fatigue—Doxorubicin—ovarian cancer	0.000277	0.000787	CcSEcCtD
Amiloride—Pain—Doxorubicin—ovarian cancer	0.000275	0.00078	CcSEcCtD
Amiloride—Constipation—Doxorubicin—ovarian cancer	0.000275	0.00078	CcSEcCtD
Amiloride—Abdominal pain—Epirubicin—ovarian cancer	0.000275	0.00078	CcSEcCtD
Amiloride—SLC9A1—Disease—SLC2A1—ovarian cancer	0.000266	0.000932	CbGpPWpGaD
Amiloride—Feeling abnormal—Doxorubicin—ovarian cancer	0.000265	0.000752	CcSEcCtD
Amiloride—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000263	0.000746	CcSEcCtD
Amiloride—Abdominal pain—Doxorubicin—ovarian cancer	0.000254	0.000721	CcSEcCtD
Amiloride—Asthenia—Epirubicin—ovarian cancer	0.000249	0.000708	CcSEcCtD
Amiloride—PLAU—Hemostasis—PIK3CD—ovarian cancer	0.000248	0.000869	CbGpPWpGaD
Amiloride—Pruritus—Epirubicin—ovarian cancer	0.000246	0.000698	CcSEcCtD
Amiloride—Diarrhoea—Epirubicin—ovarian cancer	0.000238	0.000675	CcSEcCtD
Amiloride—SLC9A1—Metabolism—FASN—ovarian cancer	0.000235	0.000821	CbGpPWpGaD
Amiloride—Asthenia—Doxorubicin—ovarian cancer	0.000231	0.000655	CcSEcCtD
Amiloride—SLC9A1—Metabolism—SLC5A5—ovarian cancer	0.000231	0.000808	CbGpPWpGaD
Amiloride—Dizziness—Epirubicin—ovarian cancer	0.00023	0.000652	CcSEcCtD
Amiloride—Pruritus—Doxorubicin—ovarian cancer	0.000228	0.000646	CcSEcCtD
Amiloride—SLC9A1—Disease—PPP2R1A—ovarian cancer	0.000226	0.000792	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000225	0.000789	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC2A1—ovarian cancer	0.000223	0.00078	CbGpPWpGaD
Amiloride—Vomiting—Epirubicin—ovarian cancer	0.000221	0.000627	CcSEcCtD
Amiloride—Diarrhoea—Doxorubicin—ovarian cancer	0.00022	0.000624	CcSEcCtD
Amiloride—Rash—Epirubicin—ovarian cancer	0.000219	0.000622	CcSEcCtD
Amiloride—Dermatitis—Epirubicin—ovarian cancer	0.000219	0.000621	CcSEcCtD
Amiloride—Headache—Epirubicin—ovarian cancer	0.000218	0.000618	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000218	0.000762	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CB—ovarian cancer	0.000216	0.000757	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP1B1—ovarian cancer	0.000214	0.000748	CbGpPWpGaD
Amiloride—Dizziness—Doxorubicin—ovarian cancer	0.000213	0.000603	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000211	0.000738	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.00021	0.000735	CbGpPWpGaD
Amiloride—Nausea—Epirubicin—ovarian cancer	0.000207	0.000586	CcSEcCtD
Amiloride—Vomiting—Doxorubicin—ovarian cancer	0.000205	0.00058	CcSEcCtD
Amiloride—Rash—Doxorubicin—ovarian cancer	0.000203	0.000575	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000203	0.00071	CbGpPWpGaD
Amiloride—Dermatitis—Doxorubicin—ovarian cancer	0.000203	0.000575	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000202	0.000708	CbGpPWpGaD
Amiloride—Headache—Doxorubicin—ovarian cancer	0.000202	0.000572	CcSEcCtD
Amiloride—PLAU—Hemostasis—IL2—ovarian cancer	0.000199	0.000695	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000197	0.000688	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000196	0.000685	CbGpPWpGaD
Amiloride—Nausea—Doxorubicin—ovarian cancer	0.000191	0.000542	CcSEcCtD
Amiloride—SLC9A1—Metabolism—PPP2R1A—ovarian cancer	0.00019	0.000664	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000189	0.000661	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000188	0.00066	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TERT—ovarian cancer	0.00018	0.000629	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCB1—ovarian cancer	0.000176	0.000616	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TYMS—ovarian cancer	0.000173	0.000605	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000172	0.000602	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—ovarian cancer	0.000169	0.000591	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NRAS—ovarian cancer	0.000167	0.000584	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CAV1—ovarian cancer	0.000166	0.000582	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NME2—ovarian cancer	0.000165	0.000577	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00016	0.00056	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK3—ovarian cancer	0.00016	0.000559	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6ST—ovarian cancer	0.000158	0.000552	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NME2—ovarian cancer	0.000154	0.000538	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK1—ovarian cancer	0.000152	0.000532	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APC—ovarian cancer	0.000151	0.00053	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000149	0.000522	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—KRAS—ovarian cancer	0.000143	0.000502	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CAV1—ovarian cancer	0.000139	0.000488	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CD—ovarian cancer	0.000133	0.000466	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—ovarian cancer	0.000132	0.000462	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—ovarian cancer	0.000128	0.000446	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CG—ovarian cancer	0.000127	0.000444	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HRAS—ovarian cancer	0.000122	0.000427	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—ovarian cancer	0.000118	0.000412	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTOR—ovarian cancer	0.000116	0.000406	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CB—ovarian cancer	0.000116	0.000406	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CD—ovarian cancer	0.000112	0.00039	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1B—ovarian cancer	0.000109	0.000381	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—ovarian cancer	0.000108	0.000377	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000107	0.000373	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYTB—ovarian cancer	0.000106	0.000372	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000103	0.000361	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CTNNB1—ovarian cancer	0.000103	0.00036	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTEN—ovarian cancer	0.0001	0.000351	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	9.94e-05	0.000348	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYTB—ovarian cancer	9.9e-05	0.000347	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CB—ovarian cancer	9.72e-05	0.00034	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	9.6e-05	0.000336	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BRIP1—ovarian cancer	9.29e-05	0.000325	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPP1CC—ovarian cancer	9.29e-05	0.000325	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—ovarian cancer	8.97e-05	0.000314	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NRAS—ovarian cancer	8.95e-05	0.000313	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPP1CC—ovarian cancer	8.66e-05	0.000303	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BRIP1—ovarian cancer	8.66e-05	0.000303	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK3—ovarian cancer	8.57e-05	0.0003	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTEN—ovarian cancer	8.4e-05	0.000294	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—ovarian cancer	8.33e-05	0.000292	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK1—ovarian cancer	8.15e-05	0.000285	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—ovarian cancer	8.15e-05	0.000285	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.13e-05	0.000285	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KRAS—ovarian cancer	7.7e-05	0.00027	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.66e-05	0.000268	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.58e-05	0.000265	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.14e-05	0.00025	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—ovarian cancer	7.08e-05	0.000248	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HRAS—ovarian cancer	6.55e-05	0.000229	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—ovarian cancer	6.27e-05	0.000219	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—YAP1—ovarian cancer	6.23e-05	0.000218	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.15e-05	0.000215	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—ovarian cancer	5.93e-05	0.000207	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MAPK1—ovarian cancer	5.87e-05	0.000205	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—YAP1—ovarian cancer	5.81e-05	0.000203	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—ovarian cancer	5.78e-05	0.000202	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.73e-05	0.000201	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MAPK1—ovarian cancer	5.47e-05	0.000192	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FASN—ovarian cancer	5.08e-05	0.000178	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC5A5—ovarian cancer	5e-05	0.000175	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—ovarian cancer	4.84e-05	0.000169	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A1—ovarian cancer	4.82e-05	0.000169	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FASN—ovarian cancer	4.73e-05	0.000166	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HRAS—ovarian cancer	4.71e-05	0.000165	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC5A5—ovarian cancer	4.66e-05	0.000163	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1B1—ovarian cancer	4.63e-05	0.000162	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A1—ovarian cancer	4.5e-05	0.000157	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HRAS—ovarian cancer	4.39e-05	0.000154	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1B1—ovarian cancer	4.31e-05	0.000151	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	4.1e-05	0.000144	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	3.82e-05	0.000134	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCB1—ovarian cancer	3.81e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TYMS—ovarian cancer	3.74e-05	0.000131	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCB1—ovarian cancer	3.55e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TYMS—ovarian cancer	3.49e-05	0.000122	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAV1—ovarian cancer	3.01e-05	0.000106	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAV1—ovarian cancer	2.81e-05	9.84e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CG—ovarian cancer	2.75e-05	9.61e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CG—ovarian cancer	2.56e-05	8.96e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CD—ovarian cancer	2.41e-05	8.45e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CD—ovarian cancer	2.25e-05	7.88e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CB—ovarian cancer	2.1e-05	7.37e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CB—ovarian cancer	1.96e-05	6.87e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTEN—ovarian cancer	1.82e-05	6.36e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTEN—ovarian cancer	1.69e-05	5.93e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—ovarian cancer	1.28e-05	4.49e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—ovarian cancer	1.2e-05	4.19e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—ovarian cancer	1.05e-05	3.67e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—ovarian cancer	9.76e-06	3.42e-05	CbGpPWpGaD
